Abstract
Multiple myeloma patients with plasmablastic morphology of tumor cells and extramedullary presentation of disease often have an aggressive clinical course and resistance to chemotherapy. We describe a case of an elderly patient who presented with extramedullary, IgA-lambda-secreting multiple myeloma with plasmablastic features who demonstrated impressive clinical response to single-agent lenalidomide. This is the first description of a plasmablastic variety of multiple myeloma successfully treated with lenalidomide alone.
Original language | English (US) |
---|---|
Pages (from-to) | 328-330 |
Number of pages | 3 |
Journal | Clinical lymphoma & myeloma |
Volume | 9 |
Issue number | 4 |
DOIs | |
State | Published - Aug 2009 |
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research